Search Results - "Engebraten, Olav"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review) by Friesen, Scott A, Hjortland, Geir Olav, Madsen, Steen J, Hirschberg, Henry, Engebraten, Olav, Nesland, Jahn M, Peng, Qian

    Published in International journal of oncology (01-09-2002)
    “…With current treatment methods the prognosis for patients with aggressive brain tumors is dismal. Treatment failure is usually due to local recurrence of…”
    Get more information
    Journal Article
  7. 7

    Breast cancer patient-derived explant cultures recapitulate in vivo drug responses by Pettersen, Solveig, Øy, Geir Frode, Egeland, Eivind Valen, Juell, Siri, Engebråten, Olav, Mælandsmo, Gunhild Mari, Prasmickaite, Lina

    Published in Frontiers in oncology (2023)
    “…Assessment of drug sensitivity in tumor tissue may significantly contribute to functional diagnostics to guide personalized treatment of cancer. Tumor…”
    Get full text
    Journal Article
  8. 8
  9. 9

    PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles by Engesaeter, Birgit Ø, Bonsted, Anette, Berg, Kristian, Høgset, Anders, Engebråten, Olav, Fodstad, Øystein, Curiel, David T, Maelandsmo, Gunhild M

    Published in Cancer gene therapy (01-05-2005)
    “…The development of methods for efficient and specific delivery of therapeutic genes into target tissues is an important issue for further development of in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    pH-Responsive Nano Carriers for Doxorubicin Delivery by Bagherifam, Shahla, Skjeldal, Frode Miltzow, Griffiths, Gareth, Mælandsmo, Gunhild M., Engebråten, Olav, Nyström, Bo, Hasirci, Vasif, Hasirci, Nesrin

    Published in Pharmaceutical research (01-04-2015)
    “…Purpose The aim of this study was to design stimuli-responsive nanocarriers for anti-cancer drug delivery. For this purpose, doxorubicin (DOX)-loaded,…”
    Get full text
    Journal Article
  12. 12

    Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer by Moestue, Siver A, Dam, Cornelia G, Gorad, Saurabh S, Kristian, Alexandr, Bofin, Anna, Mælandsmo, Gunhild M, Engebråten, Olav, Gribbestad, Ingrid S, Bjørkøy, Geir

    Published in Breast cancer research : BCR (28-02-2013)
    “…The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in cancer cells through numerous mutations and epigenetic changes. The recent…”
    Get full text
    Journal Article
  13. 13

    MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients by Mo, Torgeir, Brandal, Siri Helene Bertelsen, Geier, Oliver Marcel, Engebråten, Olav, Nilsen, Line Brennhaug, Kristensen, Vessela N, Hole, Knut Håkon, Hompland, Tord, Fleischer, Thomas, Seierstad, Therese

    Published in Cancers (01-09-2023)
    “…Anti-VEGF (vascular endothelial growth factor) treatment improves response rates, but not progression-free or overall survival in advanced breast cancer. It…”
    Get full text
    Journal Article
  14. 14

    Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model by Kim, Eugene, Tunset, Hanna Maja, Cebulla, Jana, Vettukattil, Riyas, Helgesen, Heidi, Feuerherm, Astrid Jullumstrø, Engebråten, Olav, Mælandsmo, Gunhild Mari, Johansen, Berit, Moestue, Siver Andreas

    Published in BMC cancer (07-03-2016)
    “…Group IVA cytosolic phospholipase A2 (cPLA2α) plays an important role in tumorigenesis and angiogenesis. It is overexpressed in basal-like breast cancer…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions by Bergholtz, Helga, Lien, Tonje G., Swanson, David M., Frigessi, Arnoldo, Daidone, Maria Grazia, Tost, Jörg, Wärnberg, Fredrik, Sørlie, Therese

    Published in NPJ breast cancer (2020)
    “…Ductal carcinoma in situ (DCIS) is a non-invasive type of breast cancer with highly variable potential of becoming invasive and affecting mortality. Currently,…”
    Get full text
    Journal Article
  17. 17

    Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells by Engesæter, Birgit Ø., Sathermugathevan, Menaka, Hellenes, Tina, Engebråten, Olav, Holm, Ruth, Flørenes, Vivi Ann, Mælandsmo, Gunhild M.

    Published in Cancer biology & therapy (01-07-2011)
    “…Melanoma is a highly aggressive malignant tumor with an exceptional ability to develop resistance and no curative therapy is available for patients with…”
    Get full text
    Journal Article
  18. 18

    Quantitative 31P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts by Esmaeili, Morteza, Bathen, Tone F., Engebråten, Olav, Mælandsmo, Gunhild M., Gribbestad, Ingrid S., Moestue, Siver A.

    Published in Magnetic resonance in medicine (01-06-2014)
    “…Purpose Phospholipid metabolites are of importance in cancer studies, and have been suggested as candidate metabolic biomarkers for response to targeted…”
    Get full text
    Journal Article
  19. 19

    In Vivo 31P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts by Esmaeili, Morteza, Moestue, Siver A., Hamans, Bob C., Veltien, Andor, Kristian, Alexandr, Engebråten, Olav, Mælandsmo, Gunhild M., Gribbestad, Ingrid S., Bathen, Tone F., Heerschap, Arend

    Published in Journal of magnetic resonance imaging (01-03-2015)
    “…Purpose To study cancer associated with abnormal metabolism of phospholipids, of which several have been proposed as biomarkers for malignancy or to monitor…”
    Get full text
    Journal Article
  20. 20